Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction

Journal of Molecular Medicine

Volumn 84, Issue 6, 2006, Pages 469-477

  Zacharowski, Kai ^a,d,e   Zacharowski, Paula ^a   Reingruber, Sonja ^b   Petzelbauer, Peter ^c,e,f  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Fibrex Medical Research and Development   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Molecular Cardioprotection and Inflammation Group   (Germany)

^e Molecular Cardioprotection and Inflammation Group ^*

^f Medical University   (United Kingdom)

Author keywords

Endothelial cell; Fibrin fragments; Leukocyte transmigration; Myocardial infarction and reperfusion injury; VE cadherin

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CTX 01; CTX 100; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; FX 06; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE; PEPTIDE B BETA[15-42]; PEXELIZUMAB; PGX 100; STEROID; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

CARDIOPULMONARY BYPASS; CELL ADHESION; CLINICAL TRIAL; DRUG HALF LIFE; DRUG TARGETING; ENDOTHELIUM CELL; EXPERIMENTATION; FIBRIN FORMATION; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MACROPHAGE; MYOCARDITIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT;

EID: 33744469804     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0051-7     Document Type: Review

References (86)

1. Tennant R, Wiggers C (1935) The effect of coronary occlusion on myocardial contraction. Am J Physiol 112:351-361
2. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H (1960) Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol 70:68-78
3. Taylor RR (1971) Myocardial potassium and ventricular arrhythmias following reperfusion of ischaemic myocardium. Aust N Z J Med 1(2):114-120
4. Hearse DJ, Chain EB (1973) Effect of glucose on enzyme release from, and recovery of, the anoxic myocardium. Recent Adv Stud Cardiac Struct Metab 3:763-772
5. Hearse DJ, Humphrey SM, Chain EB (1973) Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 5(4):395-407
6. Hearse DJ, Humphrey SM, Nayler WG, Slade A, Border D (1975) Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol 7(5):315-324
7. Hearse DJ, Humphrey SM, Bullock GR (1978) The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol 10(7):641-668
8. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML (1986) Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 74(6):1424-1433
9. Wolfe CL, Moseley ME, Wikstrom MG, Sievers RE, Wendland MF, Dupon JW, Finkbeiner WE, Lipton MJ, Parmley WW, Brasch RC (1989) Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. Circulation 80(4):969-982
10. Farb A, Kolodgie FD, Jenkins M, Virmani R (1993) Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol 21(5):1245-1253
11. Zacharowski K, Frank S, Otto M, Chatterjee PK, Cuzzocrea S, Hafner G, Pfeilschifter J, Thiemermann C (2000) Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscler Thromb Vasc Biol 20(6):1521-1528
12. Zacharowski K, Olbrich A, Piper J, Hafher G, Kondo K, Thiemermann C (1999) Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents. Arterioscler Thromb Vasc Biol 19(9):2141-2147
13. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, Castellino FJ, Groger M, Wolff K, Zacharowski K (2005) The fibrin-derived peptide B Beta (15-42) protects the myocardium against ischemia-reperfusion injury. Nat Med 11(3):298-304
14. Fan GC, Ren X, Qian J, Yuan Q, Nicolaou P, Wang Y, Jones WK, Chu G, Kranias EG (2005) Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 111(14):1792-1799
15. Armaganian L, Kam G, Eisenberg PR, Schechtman KB, Abendschein DR (2000) Role of tissue factor-mediated coagulation in ischemia/reperfusion-induced injury of Langendorf-perfused rabbit hearts. Coron Artery Dis 11(6):481-487
16. Balke CW, Kaplinsky E, Michelson EL, Naito M, Dreifus LS (1981) Reperfusion ventricular tachyarrhythmias - correlation with antecedent coronary-artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J 101(4):449-456
17. Manning AS, Hearse DJ (1984) Reperfusion-induced arrhythmias - mechanisms and prevention. J Mol Cell Cardiol 16(6):497-518
18. Bril A (1996) Cellular mechanisms of cardiac arrhythmias in the ischemic and reperfused heart. EXS 76:135-153
19. Ruiz Petrich E, Schanne OF, Ponce Zumino A (1996) Electrophysiological responses to ischemia and reperfusion. EXS 76:115-133
20. Grech ED, Ramsdale DR (1994) Termination of reperfusion arrhythmia by coronary-artery occlusion. Br Heart J 72(1):94-95
21. Vaturi M, Birnbaum Y (2000) The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction. J Thromb Thrombolysis 10(2):137-147
22. Woodcock EA, Arthur JF, Matkovich SJ (2000) Inositol 1,4,5-trisphosphate and reperfusion arrhythmias. Clin Exp Pharmacol Physiol 27(9):734-737
23. Matsumura K, Jeremy RW, Schaper J, Becker LC (1998) Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97(8):795-804
24. Gross GJ, Kersten JR, Warltier DC (1999) Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg 68(5):1898-1904
25. Heusch G, Schulz R, Rahimtoola SH (2005) Myocardial hibernation: a delicate balance. Am J Physiol Heart Circ Physiol 288(3):H984-H999
26. Bolli R (1990) Mechanism of myocardial "stunning". Circulation 82(3):723-738
27. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94(4):1621-1628
28. Kerr JF (2002) History of the events leading to the formulation of the apoptosis concept. Toxicology 181-182:471-474
29. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94(4):1621-1628
30. Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW (2004) Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled Annexin V. J Nucl Med 45(9):1536-1541
31. Bromme HJ, Holtz J (1996) Apoptosis in the heart: when and why? Mol Cell Biochem 163-164:261-275
32. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH (2005) Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 18(6):335-350
33. Horstick G, Berg O, Heimann A, Darius H, Lehr HA, Bhakdi S, Kempski O, Meyer J (1999) Surgical procedure affects physiological parameters in rat myocardial ischemia: need for mechanical ventilation. Am J Physiol 276(2 Pt 2):H472-H479
34. Christensen CW, Rieder MA, Silverstein EL, Gencheff NE (1995) Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 92(9):2617-2621
35. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ (1994) Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 93(6):2658-2666
36. Hori M, Kitakaze M, Sato H, Takashima S, Iwakura K, Inoue M, Kitabatake A, Kamada T (1991) Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation 84(5):2135-2145
37. Okamoto F, Allen BS, Buckberg GD, Bugyi H, Leaf J (1986) Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 92(3 Pt 2):613-620
38. Pisarenko OI, Shulzhenko VS, Studneva IM, Kapelko VI (1993) Effects of gradual reperfusion on postischemic metabolism and functional recovery of isolated guinea pig heart. Biochem Med Metab Biol 50(1):127-134
39. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5):1124-1136
40. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F (2005) Postconditioning - a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 100(4):295-310
41. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J (2004) Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62(1):74-85, 1-4
42. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285(2):H579-H588
43. Grech ED, Dodd NJ, Jackson MJ, Morrison WL, Faragher EB, Ramsdale DR (1996) Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol 77(2):122-127
44. Lee C, Dhalla NS, Hryshko LV (2005) Therapeutic potential of novel Na+-Ca2+ exchange inhibitors in attenuating ischemia-reperfusion injury. Can J Cardiol 21(6):509-516
45. Gaffhey PJ (2001) Fibrin degradation products. A review of structures found in vitro and in vivo. Ann N Y Acad Sci 936:594-610
46. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC (1991) CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A 88(3):1044-1048
47. Olexa SA, Budzynski AZ, Doolittle RF, Cottrell BA, Greene TC (1981) Structure of fragment E species from human cross-linked fibrin. Biochemistry 20(21):6139-6145
48. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311(8):501-505
49. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. The framingham study. JAMA 258(9):1183-1186
50. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342(8879):1076-1079
51. Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G, Koehler ED (1999) Dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J 20(20):1493-1502
52. Tataru MC, Schulte H, von Eckardstein A, Heinrich J, Assmann G, Koehler E (2001) Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Coron Artery Dis 12(3):157-165
53. Shitrit D, Bar-Gil, Shitrit A, Rudensky B, Sulkes J, Gutterer N, Zviony D (2004) Role of ELISA D-Dimer test in patients with unstable angina pectoris presenting at the emergency department with a normal electrocardiogram. Am J Hematol 77(2):147-150
54. Kontny F, Dempfle CE, Abildgaard U (1999) Fibrin monomer antigen: a novel marker of mortality in acute myocardial infarction. Eur Heart J 20(11):808-812
55. Saigo M, Waters DD, Abe S, Biro S, Minagoe S, Maruyama I, Tei C (2004) Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, D-Dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarctiona
56. Perez RL, Roman J (1995) Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol 154(4):1879-1887
57. Qi J, Kreutzer DL (1995) Fibrin activation of vascular endothelial cells. Induction of IL-8 expression. J Immunol 155(2):867-876
58. Harley SL, Sturge J, Powell JT (2000) Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterioscler Thromb Vasc Biol 20(3):652-658
59. Szaba FM, Smiley ST (2002) Roles for thrombin and fibrin (ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99(3):1053-1059
60. Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG (2001) Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol 281(6):F1157-F1163
61. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL (2001) Wound-healing defects in mice lacking fibrinogen. Blood 97(12):3691-3698
62. Wilberding JA, Ploplis VA, McLennan L, Liang Z, Cornelissen I, Feldman M, Deford ME, Rosen ED, Castellino FJ (2001) Development of pulmonary fibrosis in fibrinogen-deficient mice. Ann N Y Acad Sci 936:542-548
63. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL (2002) Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62(23):6966-6972
64. Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, Plow EFA (1990) Unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem 265(21):12119-12122
65. Altieri DC, Plescia J, Plow EF (1993) The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (Alpha M Beta 2, Mac-1) and promotes leukocyte adhesion. J Biol Chem 268(3):1847-1853
66. Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR (1995) Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 270(2):696-699
67. Farrell DH, Thiagarajan P, Chung DW, Davie EW (1992) Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci U S A 89(22):10729-10732
68. Suehiro K, Gailit J, Plow EF (1997) Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells. J Biol Chem 272(8):5360-5366
69. Yokoyama K, Zhang XP, Medved L, Takada Y (1999) Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains. Biochemistry 38(18):5872-5877
70. Bach TL, Barsigian C, Yaen CH, Martinez J (1998) Endothelial cell VE-cadherin functions as a receptor for the Beta15-42 sequence of fibrin. J Biol Chem 273(46):30719-30728
71. Gorlatov S, Medved L (2002) Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Biochemistry 41(12):4107-4116
72. Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, Hsu CY, Levy DE (2000) Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke treatment with ancrod trial. JAMA 283(18):2395-2403
73. Simpson PJ, Schelm JA, Smith GF (1991) Therapeutic defibrination with ancrod does not protect canine myocardium from reperfusion injury. J Pharmacol Exp Ther 256(2):780-786
74. Dempfle CE, Argiriou S, Kucher K, Muller-Peltzer H, Rubsamen K, Heene DL (2000) Analysis of fibrin formation and proteolysis during intravenous administration of ancrod. Blood 96(8):2793-2802
75. Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O, Martin TR, Pohlman TH, Verrier ED, Mackman N (2000) Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 157(6):1849-1862
76. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407(6801):258-264
77. Chalupowicz DG, Chowdhury ZA, Bach TL, Barsigian C, Martinez J (1995) Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 130(1):207-215
78. Hamaguchi M, Bunce LA, Sporn LA, Francis CW (1993) Spreading of platelets on fibrin is mediated by the Amino Terminus of the beta chain including peptide beta 15-42. Blood 81(9):2348-2356
79. Ribes JA, Ni F, Wagner DD, Francis CW (1989) Mediation of fibrin-induced release of Von Willebrand Factor from cultured endothelial cells by the fibrin beta chain. J Clin Invest 84(2):435-442
80. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA (2004) Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95(2):125-134
81. Libby P, Maroko PR, Bloor CM, Sobel BE, Braunwald E (1973) Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest 52(3):599-607
82. Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53(1):31-47
83. Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N (2003) Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 73(6):713-721
84. Entman ML, Youker KA, Frangogiannis N, Lakshminarayanan V, Nossuli T, Evans A, Kurrelmeyer K, Mann DL, Smith CW (2000) Is inflammation good for the ischemic heart-perspectives beyond the ordinary. Z Kardiol 89(Suppl 9):IX/82-IX/87
85. Zacharowski K, Olbrich A, Otto M, Hafner G, Thiemermann C (1999) Effects of the prostanoid EP3-receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat. Br J Pharmacol 126(4):849-858
86. Gaffney PJ (2001) Fibrin degradation products. A review of structures found in vitro and in vivo. Ann N Y Acad Sci 936:594-610